VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 121 filers reported holding VERVE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,470,696 | +132.1% | 186,327 | +228.3% | 0.00% | – |
| Q2 2023 | $1,064,306 | -53.4% | 56,763 | -64.2% | 0.00% | – |
| Q1 2023 | $2,283,234 | -62.5% | 158,338 | -49.6% | 0.00% | -100.0% |
| Q4 2022 | $6,084,008 | -36.3% | 314,419 | +13.1% | 0.00% | -50.0% |
| Q3 2022 | $9,553,000 | +373.2% | 278,112 | +110.5% | 0.00% | – |
| Q2 2022 | $2,019,000 | +41.2% | 132,110 | +110.8% | 0.00% | – |
| Q1 2022 | $1,430,000 | -71.4% | 62,657 | -53.8% | 0.00% | – |
| Q4 2021 | $4,996,000 | +190.6% | 135,524 | +375.1% | 0.00% | – |
| Q2 2021 | $1,719,000 | – | 28,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |